Advanced Stage Is a Risk for Severe Neutropenia in Breast Cancer Patients Undergoing Neoadjuvant Adriamycin/Cyclophosphamide/Docetaxel Chemotherapy

BACKGROUND: Severe neutropenia, including febrile neutropenia, is a major toxicity of systemic chemotherapy that leads to delays in treatment, higher costs, and mortality. Severe neutropenia may occur during neoadjuvant chemotherapy even when the patients are free from known risk factors. Pegfilgras...

Descripción completa

Detalles Bibliográficos
Autores principales: Moro, Kazuki, Nagahashi, Masayuki, Uchida, Haruka, Oji, Maiko, Tsuchida, Junko, Yamaura, Kumiko, Toshikawa, Chie, Nakano, Mae, Ikarashi, Mayuko, Muneoka, Yusuke, Tajima, Yosuke, Ichikawa, Hiroshi, Shimada, Yoshifumi, Sakata, Jun, Koyama, Yu, Takabe, Kazuaki, Wakai, Toshifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822686/
https://www.ncbi.nlm.nih.gov/pubmed/36660211
http://dx.doi.org/10.14740/wjon1530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822686/
https://www.ncbi.nlm.nih.gov/pubmed/36660211
http://dx.doi.org/10.14740/wjon1530

Ejemplares similares